Elena Elimova, MD, shares efficacy data for zanidatamab in patients with HER2-positive gastroesophageal adenocarcinoma from HERIZON-GEA-01.
Elena Elimova, MD
Advertisement
Elena Elimova, MD, is an associate professor in the Department of Medicine at the University of Toronto, as well as a staff medical oncologist at Princess Margaret Hospital.
Articles by Elena Elimova, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Key Health Care Changes During Trump’s First Year Back in Office
2
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
3
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
4
Maternal Morbidity Increased in States Enacting TRAP Laws
5
